Environmental reporting frameworks Pharma executives can use to guide their Scope 3 emissions reporting

With the climate crisis intensifying and the impending regulatory requirements for environmental reporting, there is a heightened focus on how companies are tackling environmental sustainability challenges across their supply chain operations. Sustainability reporting is becoming mandatory in many regions, and transparent reporting ensures compliance with these regulations.

The shift towards greater transparency and accountability is not only beneficial for the planet but also essential for the long-term success of businesses, building trust and credibility with stakeholders.

The implementation of global regulations and mandatory sustainability reporting is revolutionising the landscape of global supply chains, fostering a culture of environmental responsibility. By sharing sustainability initiatives and challenges transparently, pharma companies can inspire others, facilitate knowledge-sharing, and foster collaboration within and across industries.

Transparent reporting also allows companies to identify gaps, set targets, and track progress, driving continuous improvement in their sustainability practices.

This white paper offers a concise summary of key dates and milestones, to help you navigate the complexities of supply chain sustainability.

Gain valuable insights into upcoming regulatory changes to future-proof your operations. Download this white paper to understand:

  • Key environmental sustainability regulations and what they mean for the pharma industry
  • Latest corporate sustainability reporting directives
  • Next steps forsupply chain sustainability: key dates summary

*The white paper was updated to the latest 2024 information

Discover how the Hub can help organisations map their carbon footprint by effectively collecting Scope 3 emissions across their supply chain. Watch our webinar recording to learn more: "Optimising Scope 3 Emissions Reporting Across Your Supply Chain".